Primary cardiac synovial sarcoma mimicking SARS-CoV-2 associated pericarditis
Authors:
Eva Cinková; Ondrej Ondič; Alexander Malán
Authors‘ workplace:
Šiklův ústav patologie lékařské fakulty UK v Plzni a Fakultní nemocnice Plzeň
; Klinika zobrazovacích metod Fakultní nemocnice Plzeň
; II. interní klinika Fakultní nemocnice Plzeň
Published in:
Vnitř Lék 2022; 68(E-7): 23-27
Category:
Case reports
doi:
https://doi.org/10.36290/vnl.2022.102
Overview
Primary cardiac synovial sarcoma is an extremely rare tumor with a higher incidence in young men. The mean age of occurrence is 32 years. Synovial sarcomas are tumors with high aggressiveness, proliferate rapidly and metastasize to regional and distant lymph nodes or surrounding organs. The typical location of synovial sarcoma of the heart is the atrial and ventricular septum. Its size, the degree of infiltration of the surrounding tissues and the presence of metastases influence clinical symptoms, which are very non-specific. The low specificity of the symptoms complicates the clinical diagnosis and in most cases the tumor is detected during its progression or incidentally. The final diagnosis is based on histological examination. The primary and only method of treatment is a surgical solution with an effort to completely resect the tumor, followed by aggressive palliative chemotherapy.
In the following paper, we present a case report of a 32-year-old man who was diagnosed with synovial cardiac sarcoma only on the basis of exacerbation of non-specific subjective complaints due to the complication in the form of of aneurysmal bleeding of the tumor mass.
Keywords:
Chemotherapy – sarcoma – SARS‑CoV- 2 – heart tumors
Sources
1. World Health Organization Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours, 5th ed, International Agency for Research on Cancer, 2020. Vol 3.
2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7.
3. Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83.
4. Miller KD, Fidler‑Benaoudia M, Keegan TH et al. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70:443.
5. Burke A, Virmani R. Primary cardiac sarcomas. Atlas of tumor pa_thology. Tumors of the heart and great vessels. 1990;16:127-70.
6. Patel J, Sheppard MN. Pathological study of primary cardiac and pericardial tumours in a specialist UK centre: surgical and autop_sy series. Cardiovasc Pathol. 2010;19:343-52.
7. Hamidi M, Moody JS, Weigel TL, Kozak KR. Primary cardiac sarco_ma. Ann Thorac Surg. 2010;90:176-81.
8. Piazza N, Chughtai T, Toledano K et al. Primary cardiac tumors: Eighteen years of surgical experience on 21 patients. Can J Cardiol. 2004;20:1443-1448.
9. Birdsall S, Osin P, Lu YJ et al. Synovial sarcoma specific translocation associated with both epithelial and spindle cell components. Int J Cancer. 1999;82:605- 608.
10. Debourdeau P, Gligorov J, Teixeira L et al. Maligant cardiac tumors. Bull Cancer. 2004;91:136-146.
11. Sheu CC, Lin SF, Chiu CC et al. Left atrial sarcoma mimicking obstructive pulmonary disease. J Clin Oncol. 2007;25:1277.
12. Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol. 2007;64:1115.
13. Grande AM, Ragni T, Viganò M. Primary cardiac tumors. A clinical experience of 12 years. Tex Heart Inst J. 1993;20:223-30.
14. Gowdamarajan A, Michler RE. Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol. 2000;15:121-5.
15. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Car_diac tumors: diagnosis and management. Lancet Oncol. 2005;6:219-28.
16. Prosnitz RG, Chen YH, Marks LB. Cardiac toxicity following thoracic radiation. Semin Oncol. 2005;32:71-80.
17. Llombart‑Cussac A, Pivot X, Contesso G, Rhor‑Alvarado A, Delord JP, Spielmann M, Türsz T, Le Cesne A. Adjuvant chemotherapy for primary cardiac sarcoma: the IGR experience. Br J Cancer. 1998;78:1624-8.
18. Simpson L, Kumar SK, Okuno SH, Schaff HV, Porrata LF, Buckner JC, Moynihan TJ. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112:2440-6.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2022 Issue E-7
Most read in this issue
- Differential diagnosis of leukocytosis and leukopenia
- Inflammatory markers in clinical practice
- Pegvisomant in the treatment of acromegaly
- Podiatric care from diabetologists point of view